Abstract: Methods of diagnosing and/or of treating tumors by administering a nucleoside analogue which is activated by thymidylate synthase and/or thymidine kinase enzyme into a diagnostic or toxic metabolite, and uridine analogue compounds, and compositions of same having a pharmaceutically acceptable carrier. For diagnostic applications, compounds containing a label and methods of use of such compounds are described.

Abstract: A venturi scrubber plate for a waste capture system and method for a waste material entrained in a fluid flow includes an enclosure having a flood sheet over which a liquid flows into a collection trough, an exhaust device which draws the fluid flow from the enclosure, across the collection trough, and through a throat section to a primary scrubber section, the venturi scrubber plate including a plate which is mounted on and substantially covers the collection trough, which has defined therein a plurality of holes, and through which the fluid flow containing the waste material flows, wherein the plate imposes a venturi effect on the fluid flow effective to accelerate the fluid flow so that turbulent mixing of the fluid flow containing the waste material and the liquid takes place and results in improved capture of waste material by the liquid ahead of the primary scrubber section.

Abstract: The invention is a hydrophobic polyurethane foam prepared from a conventional PO/EO polyether polyol, a graft polyol and a hydrophobicity inducing surfactant. The foam is sufficiently hydrophobic to pass a stringent water impermeability test.

Abstract: An apparatus, mounted to a mold, for injecting air into a mold cavity and removing exhaust from the mold cavity, comprising: a blow cylinder body block mounted to the mold having a conduit to the mold cavity, wherein the blow cylinder body block comprises an insulator and the conduit has walls; a needle passing through the blow cylinder body block and the conduit, wherein the needle is connected to a piston, wherein the needle has a needle passage, and wherein compressed air is applied to the piston to extend the needle into the mold cavity and retract the needle from the mold cavity; and an insulator between the needle and the conduit walls.

Abstract: Methods of diagnosing and/or of treating tumors by administering a nucleoside analogue which is activated by thymidylate synthase and/or thymidine kinase enzyme into a diagnostic or toxic metabolite, and uridine analogue compounds, and compositions of same having a pharmaceutically acceptable carrier. For diagnostic applications, compounds containing a label and methods of use of such compounds are described.

Abstract: Methods of diagnosing and/or of treating tumors by administering a nucleoside analog which is activated by thymidylate synthase and/or thymidine kinase enzyme into a diagnostic or toxic metabolite, and uridine analog compounds, and compositions of same having a pharmaceutically acceptable carrier. For diagnostic applications, compounds containing a label and methods of use of such compounds are described.

Abstract: Methods of diagnosing and/or of treating tumors by administering a nucleoside analogue which is activated by thymidylate synthase and/or thymidine kinase enzyme into a diagnostic or toxic metabolite, and uridine analogue compounds, and compositions of same having a pharmaceutically acceptable carrier. For diagnostic applications, compounds containing a label and methods of use of such compounds are described.

Abstract: Methods of diagnosing and/or of treating tumors by administering a nucleoside analogue which is activated by thymidylate synthase and/or thymidine kinase enzyme into a diagnostic or toxic metabolite, and uridine analogue compounds, and compositions of same having a pharmaceutically acceptable carrier.

Abstract: Methods of diagnosing and/or of treating tumors by administering a nucleoside analogue which is activated by thymidylate synthase and/or thymidine kinase enzyme into a diagnostic or toxic metabolite, and uridine analogue compounds, and compositions of same having a pharmaceutically acceptable carrier. For diagnostic applications, compounds containing a label and methods of use of such compounds are described.

Abstract: Pharmaceutical compositions, processes for preparing the compositions and methods of using the composition are provided. The pharmaceutical composition comprises an inert core surrounded by an active coating containing one or more bisphosphonic acids or salts thereof, a seal coating surrounding the active coating and an enteric coating surrounding the seal coating. Alendronic acid and alendronate sodium trihydrate are the preferred active ingredients. The composition may be provided in the form of pellets in a capsule or Peltabs. The invention further provides methods for the treatment of disorders caused by the abnormal dissolution or deposition of calcium salts using the inventive compositions.

Abstract: The invention provides a method for the direct preparation of pure warfarin sodium from warfarin acid. The reaction is conducted in a polar organic solvent, preferably ethanol, using a volatilizable base, preferably sodium bicarbonate or sodium carbonate, at low temperature. Drying the final product is accomplished at low temperature to avoid decomposition of the final warfarin sodium product.

Abstract: A blow molded container is provided. The container has a base, a body portion attached to the base, a concave waist attached to the body portion, a dome attached to the waist, a plurality of structural ribs, and a finish attached to the dome. The dome has a plurality of panels arranged around a perimeter of the dome. The finish has an opening and a portion of the dome is located between the panels and the waist. Each of the structural ribs is located between two adjacent panels and is raised relative to the panels.

Abstract: The aggregation of platelets on the surface of a foreign body exposed to the flowing blood of a living being (such as plastic tubing, a balloon or the end of a catheter surgically inserted in a blood vessel, a stent implanted therein or synthetic grafts, which surface normal promotes such platelet aggregation to form a coating firmly affixed to that surface which would restrict the flow of blood past that surface or to form a blood clot detachable from that surface), is inhibited by a gas permeable coating on the surface of a physiologically acceptable polymer as which contains dissolved or dispersed therein a nitrosyl-containing organometallic compound, such as sodium nitroprusside, which is protected from diffusion from the coating and from direct contact with the blood and which slowly decomposes at the body temperature within the coating and in so doing releases a platelet aggregation-inhibiting amount of nitric oxide which diffuses from the coating during the period when platelet aggregation by the surfa

Abstract: A soldering flux according to the present invention is a soldering flux containing an epoxy resin and an organic carboxylic acid, wherein the epoxy resin and the organic carboxylic acid are compounded at a ratio of 1.0 equivalent of epoxy group in the epoxy resin to 0.8-2.0 equivalent of carboxyl group in the organic carboxylic acid, and a total amount of the epoxy resin and the organic carboxylic acid is 70% or more by weight based on the total weight of the soldering flux. A lead-free solder composition according to the present invention is a solder composition containing the soldering flux and a lead-free solder. The soldering flux or the lead-free solder composition according to the present invention has special advantages of maintaining an activation by the flux, good wettability of the solder, and no inhibition of a sealing resin from curing.